Maxcyte (MXCT) Acquisitions (2025)
Maxcyte (MXCT) posted quarterly Acquisitions of $1.8 million for Q1 2025.
Maxcyte (MXCT) Acquisitions (2025) Analysis & Trends
Maxcyte (MXCT) has reported Acquisitions for 1 consecutive years, with $1.8 million the latest figure, recorded in Q1 2025.
- In Q1 2025, Acquisitions changed N/A year-over-year to $1.8 million; the TTM figure through Dec 2025 stood at $1.8 million (changed N/A YoY), while the FY2025 annual figure was $1.8 million, changed N/A from the prior year.
- Acquisitions steadied at $1.8 million in Q1 2025 per MXCT's latest filing.
- Across five years, Acquisitions topped out at $1.8 million in Q1 2025 and bottomed at $1.8 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.34 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.40 Bn | 123.93 Bn | 4.50 Bn | 437.00 Mn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 406.00 Mn |
| 4 | Boston Scientific | 73.24 Bn | 72.71 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.70 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.39 Bn | 32.44 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | -4.00 Mn |
| 8 | Koninklijke Philips | 26.34 Bn | 23.02 Bn | 4.55 Bn | -3.49 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 16.00 Mn |
| 10 | Maxcyte | 147.42 Mn | 147.42 Mn | 5.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.77 Mn |